IRCT20210830052332N1尚未招募1 期
Assessment of Efficacy and Safety of the allogeneic adipose derived mesenchymal stem cells along with platelet rich fibrin in 24 patients with perianal fistulas: a phase 1 and 2 pilot randomized, single blinded trial
Iranian academic center for education culture and research0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 years 至 no limit（—）
- 性别
- All
入选标准
- •Complex anal fistula recurrent fistula, high trans sphincteric fistula, supra sphincteric fistula, extra sphincteric fistula, and horseshoe fistula
- •patient who is older than 18 years of age
- •Patients who can sign informed consent
排除标准
- •Patients with Crohn's disease, HIV, BCG and hepatitis
- •Significant Medical Comorbidity such as Active Cardiac Angina Uncontrolled Diabetes Mellitus and Active Collagen Vascular Disease Renal and Hepatic Failure
- •Pregnancy or breastfeeding
- •Neoplasia or anorectal cancer
- •Alcohol and drug addiction
- •Undischarged perianal fistula
- •Patients taking immunosuppressive drugs
- •Bone Marrow Dysfunction
研究者
相似试验
招募中
1 期
Evaluation of the safety and efficacy of allogeneic activated Natural killer cells in metastatic Colon AdenocarcinomaIRCT20230704058675N1Middle East Gene Therapy corporation10
已完成
1 期
Evaluation of the safety and efficacy of allogeneic hematopoietic stem cell transplantation (HSCT) using alemtuzumab for patients with aplastic anemiaAplastic anemiaJPRN-C000000356GCP-ISS HE0403 group38
已完成
1 期
Evaluation of the safety and efficacy of allogenic hematopoietic stem cell transplantation (HSCT) from HLA-mismatched related donors using alemtuzumab in patients with hematological malignancies.Hematological malignanciesJPRN-C000000357GCP-ISS HE0402 group48
招募中
不适用
Safety and efficacy of Mesenchymal Stem Cell administration in Bronchiolitis Obliterans Syndrome.IRCT20201202049568N2Tehran University of Medical Sciences10
招募中
1 期
Application of Cord Blood Platelet Gel (CBPG) for the treatment of non-healing skin ulcers due to the cutaneous chronic GVHDIRCT20190101042197N1Royan Stem cell Technology Co.15